Φορτώνει......
Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis
BACKGROUND. Increasing evidence indicates a role for EBV in the pathogenesis of multiple sclerosis (MS). EBV-infected autoreactive B cells might accumulate in the CNS because of defective cytotoxic CD8(+) T cell immunity. We sought to determine the feasibility and safety of treating progressive MS p...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | JCI Insight |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
American Society for Clinical Investigation
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6302936/ https://ncbi.nlm.nih.gov/pubmed/30429369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.124714 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|